Methyl 4-Fluoro-2-{1H-Pyrrolo[2,3-b]Pyridin-5-yloxy}Benzoate: A Key Pharmaceutical Intermediate
Unlock advanced drug synthesis with this critical intermediate for cancer therapeutics.
Get a Quote & SampleProduct Core Value
![Methyl 4-Fluoro-2-{1H-Pyrrolo[2,3-b]Pyridin-5-yloxy}Benzoate](https://www.nbinno.com/webimg/gemini_6880b317b7cdf_1753264919.png)
Methyl 4-Fluoro-2-{1H-Pyrrolo[2,3-b]Pyridin-5-yloxy}Benzoate
This compound serves as a vital pharmaceutical intermediate, primarily recognized for its indispensable role in the synthesis of Venetoclax (ABT-199). Venetoclax is a groundbreaking BCL-2 inhibitor employed in the treatment of various cancers, including chronic lymphocytic leukemia and estrogen receptor-positive breast cancer. Its utility extends to research and development, facilitating the creation of novel therapeutic agents and contributing significantly to the advancement of oncology treatments.
- This Methyl 4-Fluoro-2-{1H-Pyrrolo[2,3-b]Pyridin-5-yloxy}Benzoate intermediate for Venetoclax synthesis is crucial for developing advanced cancer therapies.
- As a CAS 1235865-75-4 pharmaceutical intermediate, it meets stringent quality standards required for drug development.
- The compound's application in ABT-199 synthesis underscores its importance in targeted cancer treatment.
- Manufacturers specializing in BCL-2 inhibitor precursors rely on its consistent quality and availability.
Key Advantages
Purity and Quality Assurance
As a high purity chemical supplier for pharmaceutical applications, we ensure that every batch of Methyl 4-Fluoro-2-{1H-Pyrrolo[2,3-b]Pyridin-5-yloxy}Benzoate meets rigorous quality control standards, essential for successful drug development.
Enabling Advanced Therapies
Our role as a pharmaceutical intermediate supplier directly supports the development of innovative treatments, particularly in the field of oncology, by providing essential building blocks for drugs like Venetoclax.
Facilitating Research and Development
The availability of custom synthesis for venetoclax intermediates allows researchers and pharmaceutical companies to accelerate their drug discovery and development pipelines, leading to faster market entry for new medications.
Key Applications
Venetoclax Synthesis
This compound is a critical building block in the multi-step synthesis of Venetoclax, a targeted therapy for certain types of leukemia and lymphoma.
Oncology Drug Development
Its use extends to the broader field of oncology drug development, serving as a precursor for other BCL-2 inhibitors and related anti-cancer agents.
Pharmaceutical R&D
Researchers in pharmaceutical R&D leverage this intermediate for exploring new drug candidates and optimizing existing synthesis routes.
Custom Synthesis Projects
Companies requiring bespoke chemical synthesis for their proprietary drug development projects can utilize this intermediate as a starting point.